HOME › DRUGS › CILASTATIN SODIUM
ACTIVE SUBSTANCE / INN

CILASTATIN SODIUM

Brand name(s): RECARBRIO, PRIMAXIN, IMIPENEM AND CILASTATIN
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA207594
ANDA062756
ACTIVE SUBSTANCE
Cilastatin Sodium
REGULATORS
FDA
SPONSORS / MAH
MERCK, HQ SPCLT PHARMA, MSD MERCK CO
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PRIMAXINANDA062756MERCKDiscontinued
IMIPENEM AND CILASTATINANDA207594HQ SPCLT PHARMAPrescription
PRIMAXINNDA050587MERCKPrescription
RECARBRIONDA212819MSD MERCK COPrescription
IMIPENEM AND CILASTATINANDA090825HOSPIRA INCDiscontinued

FULL INTELLIGENCE ON CILASTATIN SODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →